{"accidental exposure to product": 16.52, "acne": 10.6, "acute myocardial infarction": 20.99, "aggression": 4.16, "angina pectoris": 3.77, "arteriosclerosis": 13.73, "atrial fibrillation": 2.44, "blood testosterone decreased": 97.29, "blood testosterone increased": 465.64, "cardiac failure congestive": 2.89, "cardiomyopathy": 9.6, "cerebrovascular accident": 5.44, "coronary artery disease": 15.3, "deep vein thrombosis": 16.85, "drug abuse": 13.87, "erectile dysfunction": 6.57, "hair growth abnormal": 31.67, "idiopathic intracranial hypertension": 65.22, "intentional product misuse": 2.88, "left ventricular hypertrophy": 24.03, "myocardial infarction": 5.47, "obstructive sleep apnoea syndrome": 49.18, "off label use": 2.79, "osteonecrosis": 9.87, "polycythaemia": 252.5, "precocious puberty": 239.03, "product quality issue": 15.33, "product use in unapproved indication": 3.7, "product use issue": 10.43, "prostatic specific antigen increased": 11.34, "pulmonary embolism": 9.51, "thrombosis": 3.39, "transgender hormonal therapy": 4628.43, "virilism": 1286.9}